A detailed history of Aft, Forsyth & Company, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Aft, Forsyth & Company, Inc. holds 7,575 shares of PFE stock, worth $219,069. This represents 0.12% of its overall portfolio holdings.

Number of Shares
7,575
Previous 11,648 34.97%
Holding current value
$219,069
Previous $335,000 37.31%
% of portfolio
0.12%
Previous 0.21%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$25.89 - $29.73 $105,449 - $121,090
-4,073 Reduced 34.97%
7,575 $210,000
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $29,396 - $38,182
-1,125 Reduced 8.81%
11,648 $335,000
Q3 2023

Nov 07, 2023

SELL
$32.09 - $37.51 $23,265 - $27,194
-725 Reduced 5.37%
12,773 $423,000
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $37,926 - $43,879
-1,050 Reduced 7.22%
13,498 $495,000
Q2 2022

Jul 28, 2022

BUY
$46.53 - $55.17 $38,387 - $45,515
825 Added 6.01%
14,548 $763,000
Q1 2022

May 10, 2022

BUY
$45.75 - $56.69 $9,150 - $11,338
200 Added 1.48%
13,723 $710,000
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $42,353 - $62,781
1,025 Added 8.2%
13,523 $799,000
Q2 2021

Jul 15, 2021

BUY
$35.91 - $40.68 $18,852 - $21,357
525 Added 4.38%
12,498 $489,000
Q4 2020

Feb 09, 2021

SELL
$33.47 - $42.56 $6,526 - $8,299
-195 Reduced 1.6%
11,973 $441,000
Q3 2020

Nov 05, 2020

SELL
$31.75 - $37.25 $4,762 - $5,587
-150 Reduced 1.22%
12,168 $447,000
Q1 2020

May 11, 2020

SELL
$27.03 - $38.62 $54,060 - $77,240
-2,000 Reduced 13.97%
12,318 $381,000
Q4 2019

Feb 10, 2020

SELL
$32.92 - $37.36 $7,407 - $8,406
-225 Reduced 1.55%
14,318 $561,000
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $4,873 - $6,319
-150 Reduced 1.02%
14,543 $523,000
Q2 2019

Jul 29, 2019

BUY
$36.98 - $41.52 $22,187 - $24,912
600 Added 4.26%
14,693 $637,000
Q1 2019

May 08, 2019

BUY
$37.5 - $41.2 $4,687 - $5,150
125 Added 0.89%
14,093 $599,000
Q4 2018

Feb 05, 2019

SELL
$38.47 - $43.86 $3,577 - $4,078
-93 Reduced 0.66%
13,968 $610,000
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $3,067 - $3,269
93 Added 0.67%
14,061 $510,000
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $17,805 - $20,657
-558 Reduced 3.84%
13,968 $496,000
Q4 2017

Feb 12, 2018

BUY
$33.26 - $35.29 $483,134 - $512,622
14,526
14,526 $526,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $162B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Aft, Forsyth & Company, Inc. Portfolio

Follow Aft, Forsyth & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aft, Forsyth & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aft, Forsyth & Company, Inc. with notifications on news.